Literature DB >> 24865983

Impairments of hepatic gluconeogenesis and ketogenesis in PPARα-deficient neonatal mice.

David G Cotter1, Baris Ercal2, D André d'Avignon3, Dennis J Dietzen4, Peter A Crawford5.   

Abstract

Peroxisome proliferator activated receptor-α (PPARα) is a master transcriptional regulator of hepatic metabolism and mediates the adaptive response to fasting. Here, we demonstrate the roles for PPARα in hepatic metabolic adaptations to birth. Like fasting, nutrient supply is abruptly altered at birth when a transplacental source of carbohydrates is replaced by a high-fat, low-carbohydrate milk diet. PPARα-knockout (KO) neonatal mice exhibit relative hypoglycemia due to impaired conversion of glycerol to glucose. Although hepatic expression of fatty acyl-CoA dehydrogenases is imparied in PPARα neonates, these animals exhibit normal blood acylcarnitine profiles. Furthermore, quantitative metabolic fate mapping of the medium-chain fatty acid [(13)C]octanoate in neonatal mouse livers revealed normal contribution of this fatty acid to the hepatic TCA cycle. Interestingly, octanoate-derived carbon labeled glucose uniquely in livers of PPARα-KO neonates. Relative hypoketonemia in newborn PPARα-KO animals could be mechanistically linked to a 50% decrease in de novo hepatic ketogenesis from labeled octanoate. Decreased ketogenesis was associated with diminished mRNA and protein abundance of the fate-committing ketogenic enzyme mitochondrial 3-hydroxymethylglutaryl-CoA synthase (HMGCS2) and decreased protein abundance of the ketogenic enzyme β-hydroxybutyrate dehydrogenase 1 (BDH1). Finally, hepatic triglyceride and free fatty acid concentrations were increased 6.9- and 2.7-fold, respectively, in suckling PPARα-KO neonates. Together, these findings indicate a primary defect of gluconeogenesis from glycerol and an important role for PPARα-dependent ketogenesis in the disposal of hepatic fatty acids during the neonatal period.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  3-hydroxymethylglutaryl-CoA synthase; glucose homeostasis; ketone body metabolism; metabolic adaptation to birth; nuclear magnetic resonance substrate fate mapping; peroxisome proliferator-activated receptor-α

Mesh:

Substances:

Year:  2014        PMID: 24865983      PMCID: PMC4101633          DOI: 10.1152/ajpendo.00087.2014

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  49 in total

1.  Obligate role for ketone body oxidation in neonatal metabolic homeostasis.

Authors:  David G Cotter; D André d'Avignon; Anna E Wentz; Mary L Weber; Peter A Crawford
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

2.  SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production.

Authors:  Tadahiro Shimazu; Matthew D Hirschey; Lan Hua; Kristin E Dittenhafer-Reed; Bjoern Schwer; David B Lombard; Yu Li; Jakob Bunkenborg; Frederick W Alt; John M Denu; Matthew P Jacobson; Eric Verdin
Journal:  Cell Metab       Date:  2010-12-01       Impact factor: 27.287

3.  Identification of a physiologically relevant endogenous ligand for PPARalpha in liver.

Authors:  Manu V Chakravarthy; Irfan J Lodhi; Li Yin; Raghu R V Malapaka; H Eric Xu; John Turk; Clay F Semenkovich
Journal:  Cell       Date:  2009-07-30       Impact factor: 41.582

Review 4.  Peroxisome proliferator-activated receptor alpha target genes.

Authors:  S Mandard; M Müller; S Kersten
Journal:  Cell Mol Life Sci       Date:  2004-02       Impact factor: 9.261

5.  Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.

Authors:  Michael K Badman; Pavlos Pissios; Adam R Kennedy; George Koukos; Jeffrey S Flier; Eleftheria Maratos-Flier
Journal:  Cell Metab       Date:  2007-06       Impact factor: 27.287

6.  Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates.

Authors:  Ronit Shiri-Sverdlov; Kristiaan Wouters; Patrick J van Gorp; Marion J Gijbels; Benoit Noel; Laurent Buffat; Bart Staels; Nobuyo Maeda; Marc van Bilsen; Marten H Hofker
Journal:  J Hepatol       Date:  2005-12-20       Impact factor: 25.083

7.  Liver-specific silencing of the human gene encoding succinyl-CoA: 3-ketoacid CoA transferase.

Authors:  Kenji E Orii; Toshiyuki Fukao; Xiang-Qian Song; Grant A Mitchell; Naomi Kondo
Journal:  Tohoku J Exp Med       Date:  2008-07       Impact factor: 1.848

8.  A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease.

Authors:  C Fernández-Miranda; M Pérez-Carreras; F Colina; G López-Alonso; C Vargas; J A Solís-Herruzo
Journal:  Dig Liver Dis       Date:  2008-03       Impact factor: 4.088

9.  Direct assessment of hepatic mitochondrial oxidative and anaplerotic fluxes in humans using dynamic 13C magnetic resonance spectroscopy.

Authors:  Douglas E Befroy; Rachel J Perry; Nimit Jain; Sylvie Dufour; Gary W Cline; Jeff K Trimmer; Julia Brosnan; Douglas L Rothman; Kitt Falk Petersen; Gerald I Shulman
Journal:  Nat Med       Date:  2013-12-08       Impact factor: 53.440

10.  Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling.

Authors:  Maryam Rakhshandehroo; Linda M Sanderson; Merja Matilainen; Rinke Stienstra; Carsten Carlberg; Philip J de Groot; Michael Müller; Sander Kersten
Journal:  PPAR Res       Date:  2007       Impact factor: 4.964

View more
  12 in total

1.  Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia.

Authors:  David G Cotter; Baris Ercal; Xiaojing Huang; Jamison M Leid; D André d'Avignon; Mark J Graham; Dennis J Dietzen; Elizabeth M Brunt; Gary J Patti; Peter A Crawford
Journal:  J Clin Invest       Date:  2014-10-27       Impact factor: 14.808

2.  PPARα augments heart function and cardiac fatty acid oxidation in early experimental polymicrobial sepsis.

Authors:  Stephen W Standage; Brock G Bennion; Taft O Knowles; Dolena R Ledee; Michael A Portman; John K McGuire; W Conrad Liles; Aaron K Olson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-11-23       Impact factor: 4.733

3.  CDKN2A/p16INK4a suppresses hepatic fatty acid oxidation through the AMPKα2-SIRT1-PPARα signaling pathway.

Authors:  Yann Deleye; Alexia Karen Cotte; Sarah Anissa Hannou; Nathalie Hennuyer; Lucie Bernard; Bruno Derudas; Sandrine Caron; Vanessa Legry; Emmanuelle Vallez; Emilie Dorchies; Nathalie Martin; Steve Lancel; Jean Sébastien Annicotte; Kadiombo Bantubungi; Albin Pourtier; Violeta Raverdy; François Pattou; Philippe Lefebvre; Corinne Abbadie; Bart Staels; Joel T Haas; Réjane Paumelle
Journal:  J Biol Chem       Date:  2020-10-09       Impact factor: 5.157

Review 4.  Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease.

Authors:  Raja Gopal Reddy Mooli; Sadeesh K Ramakrishnan
Journal:  Front Physiol       Date:  2022-07-04       Impact factor: 4.755

Review 5.  β-Hydroxybutyrate in Cardiovascular Diseases : A Minor Metabolite of Great Expectations.

Authors:  Shao Wei; Liu Binbin; Wu Yuan; Zhang Zhong; Lin Donghai; Huang Caihua
Journal:  Front Mol Biosci       Date:  2022-06-13

Review 6.  Interactions between nuclear receptors glucocorticoid receptor α and peroxisome proliferator-activated receptor α form a negative feedback loop.

Authors:  Hongjiao Gao; Yujue Li; Xiang Chen
Journal:  Rev Endocr Metab Disord       Date:  2022-04-27       Impact factor: 9.306

7.  Glucocorticoid receptor-PPARα axis in fetal mouse liver prepares neonates for milk lipid catabolism.

Authors:  Gianpaolo Rando; Chek Kun Tan; Nourhène Khaled; Alexandra Montagner; Nicolas Leuenberger; Justine Bertrand-Michel; Eeswari Paramalingam; Hervé Guillou; Walter Wahli
Journal:  Elife       Date:  2016-07-01       Impact factor: 8.140

8.  β-Hydroxybutyrate is reduced in humans with obesity-related NAFLD and displays a dose-dependent effect on skeletal muscle mitochondrial respiration in vitro.

Authors:  Jacob T Mey; Melissa L Erickson; Christopher L Axelrod; William T King; Chris A Flask; Arthur J McCullough; John P Kirwan
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-05-12       Impact factor: 4.310

9.  Hepatic adaptations to maintain metabolic homeostasis in response to fasting and refeeding in mice.

Authors:  C E Geisler; C Hepler; M R Higgins; B J Renquist
Journal:  Nutr Metab (Lond)       Date:  2016-09-26       Impact factor: 4.169

10.  Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity.

Authors:  Marion Régnier; Arnaud Polizzi; Sarra Smati; Céline Lukowicz; Anne Fougerat; Yannick Lippi; Edwin Fouché; Frédéric Lasserre; Claire Naylies; Colette Bétoulières; Valentin Barquissau; Etienne Mouisel; Justine Bertrand-Michel; Aurélie Batut; Talal Al Saati; Cécile Canlet; Marie Tremblay-Franco; Sandrine Ellero-Simatos; Dominique Langin; Catherine Postic; Walter Wahli; Nicolas Loiseau; Hervé Guillou; Alexandra Montagner
Journal:  Sci Rep       Date:  2020-04-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.